RH&PARTNER Investment Funds - RH&F Global Life Sciences Fund Class I Fonds
97,79
CHF
-0,29
CHF
-0,30
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Charles River Laboratories International Inc | US1598641074 | 4,53% |
| Bio-Techne Corp | US09073M1045 | 4,46% |
| Nektar Therapeutics | US6402681083 | 4,36% |
| Illumina Inc | US4523271090 | 3,93% |
| Exelixis Inc | US30161Q1040 | 3,87% |
| Alkermes PLC | IE00B56GVS15 | 3,72% |
| IQVIA Holdings Inc | US46266C1053 | 3,65% |
| Biogen Inc | US09062X1037 | 3,59% |
| Amgen Inc | US0311621009 | 3,57% |
| Incyte Corp | US45337C1027 | 3,53% |
| Sonstige | 60,79% |